Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 785874 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1114695 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1192640 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1245060 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1297313 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1386702 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1432633 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1582693 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1603566 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1632712 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1651663 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1679687 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1707436 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | URIC ACID (M-H)- | 1755934 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2167515 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2193046 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2201797 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2203905 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2272791 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2322806 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2463979 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2555629 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2629429 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2724789 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2909978 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2954090 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 2954980 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | URIC ACID (M+H)+ | 3839136 | Peak area normalized | female | diabetic | no neuropathy |